1. Home
  2. WAT vs KOF Comparison

WAT vs KOF Comparison

Compare WAT & KOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAT
  • KOF
  • Stock Information
  • Founded
  • WAT 1958
  • KOF 1979
  • Country
  • WAT United States
  • KOF Mexico
  • Employees
  • WAT N/A
  • KOF N/A
  • Industry
  • WAT Biotechnology: Laboratory Analytical Instruments
  • KOF Beverages (Production/Distribution)
  • Sector
  • WAT Industrials
  • KOF Consumer Staples
  • Exchange
  • WAT Nasdaq
  • KOF Nasdaq
  • Market Cap
  • WAT 17.4B
  • KOF 17.5B
  • IPO Year
  • WAT 1995
  • KOF 1993
  • Fundamental
  • Price
  • WAT $371.69
  • KOF $90.68
  • Analyst Decision
  • WAT Buy
  • KOF Buy
  • Analyst Count
  • WAT 13
  • KOF 3
  • Target Price
  • WAT $379.00
  • KOF $105.33
  • AVG Volume (30 Days)
  • WAT 670.2K
  • KOF 225.9K
  • Earning Date
  • WAT 11-04-2025
  • KOF 10-24-2025
  • Dividend Yield
  • WAT N/A
  • KOF 4.41%
  • EPS Growth
  • WAT 3.82
  • KOF 8.54
  • EPS
  • WAT 10.88
  • KOF 6.13
  • Revenue
  • WAT $3,105,638,000.00
  • KOF $15,805,291,584.00
  • Revenue This Year
  • WAT $7.12
  • KOF $7.84
  • Revenue Next Year
  • WAT $6.22
  • KOF $7.03
  • P/E Ratio
  • WAT $34.17
  • KOF $14.71
  • Revenue Growth
  • WAT 6.90
  • KOF 8.34
  • 52 Week Low
  • WAT $275.05
  • KOF $72.68
  • 52 Week High
  • WAT $423.56
  • KOF $101.74
  • Technical
  • Relative Strength Index (RSI)
  • WAT 71.44
  • KOF 64.86
  • Support Level
  • WAT $340.09
  • KOF $85.35
  • Resistance Level
  • WAT $382.02
  • KOF $89.24
  • Average True Range (ATR)
  • WAT 11.25
  • KOF 2.01
  • MACD
  • WAT 1.45
  • KOF 0.43
  • Stochastic Oscillator
  • WAT 75.62
  • KOF 97.63

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

About KOF Coca Cola Femsa S.A.B. de C.V.

Coca-Cola Femsa, a subsidiary of Femsa, is the largest franchise bottler of Coca-Cola in volume terms. The company purchases beverage concentrates and syrup from Coca-Cola, which it then processes and packages for distribution through modern trade, traditional trade, and the on-premises channel. Mexico and Brazil make up 80% of total volume and sales, with the rest from other Central and South American countries, including Panama, Guatemala, Uruguay, and Argentina. Femsa and Coca-Cola hold 47% and 28% economic interests in Coca-Cola Femsa through nonpublicly traded A and D shares, respectively, while controlling 56% and 33% of the voting power.

Share on Social Networks: